Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Targeted COVID-19 more effective than random testing
Tue September 29th - A focused COVID-19 strategy that tests groups that are most at risk of having and passing on the disease should be introduced, scientists have urged. More
Preventing heart disease would keep people employed
Tue September 29th - Preventative strategies that delay the onset of coronary heart disease would keep people in employment and save nearly 15 US billion dollars, according to a new Australian study. More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...

Red wine compound investigated for hypertension care

Thursday May 23rd, 2019

A compound produced by fruits in response to injury or attack could hold the key for to new treatments for hypertension, researchers report today.

The compound, resveratrol, is already widely consumed as a supplement and is found in red wine.

It has previously been investigated for its impact on a range of diseases including cancer and dementia.

Now, researchers from King’s College London, UK, report on their study that suggests resveratrol can help reduce high blood pressure. Findings are published in Circulation.

The team gave mice with high blood pressure 320mg per kg body weight of resveratrol for 15 days, and their blood pressure fell by about 20mmHg compared to mice on a normal diet.

In mechanism behind resveratrol’s effect appears to be causing blood vessels to relax, and hence blood pressure to drop, by oxidising a protein in the blood vessel wall. It was also seen to work the same way in tests on cells from human blood vessels.

Researcher Dr Joseph Burgoyne says no current blood pressure medications target this specific pathway, so their findings could lead to new therapies. He adds that although resveratrol was previously thought to be an antioxidant, it actually acts as an oxidant.

Resveratrol is present in red wine. The dose required to benefit blood pressure would be the equivalent of drinking 1,000 bottles per day, the researchers say.

Dr Burgoyne said: “We’re slowly realising that oxidants aren’t always the villain. Our research shows that a molecule once deemed an antioxidant exerts its beneficial effects through oxidation. We think that many other so-called antioxidants might also work in this way.

“Our work could lay the foundations for chemically altering resveratrol to improve its delivery to the body, or designing new, more potent drugs which use the same pathway."

Burgoyne, J. et al. Circulation 23 May 2019

Tags: Diet & Food | Drug & Alcohol Abuse | Heart Health | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)